Ryan Specialty (NYSE:RYAN) Price Target Raised to $55.00

Ryan Specialty (NYSE:RYAN – Get Free Report) had its price target boosted by equities researchers at Keefe, Bruyette & Woods from $49.00 to $55.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Keefe, Bruyette & Woods‘s price objective suggests a potential upside of 15.77% from the stock’s current price.

A number of other research analysts have also weighed in on RYAN. Cantor Fitzgerald boosted their target price on Ryan Specialty from $34.00 to $41.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Mizuho raised their price target on Ryan Specialty from $40.00 to $48.00 and gave the company a “neutral” rating in a report on Friday, November 13th. Morgan Stanley lifted their price objective on shares of Ryan Specialty from $50.00 to $55.00 and gave the stock an “overweight” rating in a research report on Monday. JPMorgan Chase & Co. lifted their price objective on shares of Ryan Specialty from $39.00 to $45.00 and gave the stock an “underweight” rating in a research report on Monday, August 3rd. Finally, Royal Bank Of Canada decreased their price objective on shares of Ryan Specialty from $55.00 to $52.00 and set an “outperform” rating on the stock in a report on Friday, October 30th. Eight equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty currently has an average rating of “Hold” and a consensus target price of $52.97.

Get Our Latest Analysis on Ryan Specialty

Ryan Specialty Stock Performance

NYSE:RYAN traded up $0.89 on Friday, hitting $47.51. The company’s stock had a trading volume of 50,138 shares, compared to its average volume of 2,185,638. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 4.03. The stock has a fifty day moving average of $41.75 and a two-hundred day moving average of $38.99. The firm has a market capitalization of $11.95 billion, a P/E ratio of 58.69, a price-to-earnings-growth ratio of 1.02 and a beta of 0.54. Ryan Specialty has a one year low of $29.28 and a one year high of $58.91.

Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The company reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.02. Ryan Specialty had a return on equity of 47.77% and a net margin of 8.25%. The company had revenue of $789.96 million during the quarter, compared to analysts’ expectations of $792.99 million. During the same period last year, the firm posted $0.47 earnings per share. Research analysts predict that Ryan Specialty will post 2.18 earnings per share for the current year.

Insider Transactions at Ryan Specialty

In other news, CEO Benjamin Wuller sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $47.31, for a total transaction of $2,365,500.00. Following the completion of the sale, the chief executive officer owned 94,095 shares in the company, valued at $4,451,634.45. The trade was a 34.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 52.03% of the stock is owned by company insiders.

Hedge Funds Weigh In On Ryan Specialty

A number of large investors have recently made changes to their positions in RYAN. Allworth Financial LP increased its stake in shares of Ryan Specialty by 70.0% during the second quarter. Allworth Financial LP now owns 787 shares of the company’s stock worth $30,000 after purchasing an additional 324 shares during the period. Fortitude Family Office LLC acquired a new stake in Ryan Specialty during the 3rd quarter worth approximately $34,000. Parallel Advisors LLC boosted its stake in Ryan Specialty by 54.9% in the 1st quarter. Parallel Advisors LLC now owns 1,013 shares of the company’s stock valued at $34,000 after purchasing an additional 359 shares during the period. Jacobi Capital Management LLC bought a new stake in Ryan Specialty in the 3rd quarter valued at $42,000. Finally, Integrated Wealth Concepts LLC bought a new stake in Ryan Specialty in the 2nd quarter valued at $73,000. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty is a specialty insurance organization that provides distribution, underwriting and related services to insurance brokers, agents and carriers. Its business includes wholesale brokerage, which helps insurance professionals place coverage for risks that may be difficult to insure in the standard market, and underwriting management services for specialty insurance products. The company works across a range of property and casualty insurance lines, including professional liability, transportation, property, casualty and other specialty risks.

See Also

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.